Discovery Funding Opportunities
Due Date: 10-23-2018
The purpose of this award is to support mid-career investigators with unusual promise and established records of accomplishments; candidates have a demonstrated commitment to cardiovascular or cerebrovascular science as indicated by prior publication history and scientific accomplishments.
Due Date: 10-18-2018
This FOA invites early-stage physician and other health professional investigators with a commitment to aging and/or aging-related diseases to apply for this award to advance their research and leadership skills in their specialty and in the broader field of aging and geriatrics research.
Due Date: 10-24-2018
The program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain.
Due Date: 10-29-2018
The program aims to develop accessible and affordable new tools and technologies for studying carbohydrates that will allow biomedical researchers to significantly advance our understanding of the roles of these complex molecules in health and disease.
Due Date: 10-30-2018
This program aims to support researchers to do highly innovative work on important problems in genomics. The PD/PIs should be creative investigators, early in their careers, who are part of consortia, large research groups, or other team-science efforts. PD/PIs will have flexibility to take their research in novel directions as scientific opportunities arise during this award.
Due Date: 10-31-2018
The purpose of this FOA is to establish one or two centers that can rapidly generate high quality whole genome sequence and variant data from a large number of human specimens representing two types of pediatric conditions-childhood cancers and structural birth defects.
Due Date: 11-01-2018
NCATS¿ Stem Cell Translation Laboratory (SCTL) is seeking new collaborations to help achieve common goals in induced pluripotent stem cell (iPSC) biology in a faster and more coordinated fashion
Due Date: 11-01-2018
The purpose of this FOA is to seek research applications that test innovative approaches to improve type 2 diabetes and obesity prevention and/or treatment in healthcare settings where individuals receive their medical care.
Due Date: 11-05-2018
The foundation is accepting concept papers for health and/or nutrition-related research projects focused on improving the health, nutrition, and/or development of infants and young children. In particular, the foundation is looking for practical solutions that can be rapidly implemented on a broad scale and within a predictable time frame to clinical application. Major target areas for research include new diagnostic tools that may be more rapid, more specific, more sensitive, and less invasive; new treatment regimens that are improved or novel, less stressful or painful, more targeted, have less side effects, and provide optimal dosing; symptom relief; preventative measures; assessment of deficiencies or excesses (vitamins, minerals, drugs, etc.); and risk assessment tools or measures for environmental hazards, trauma, etc.
Due Date: 11-05-2018
The Pilot/Exploratory Project Support Grant Program provides funding for investigators performing pilot/exploratory research studies that focus on improving care for seriously ill patients and their families. Investigators must conduct research projects whose purpose is to test interventions, develop research methodologies, and explore novel areas of research that are directly related to the Center's core mission and stated three areas of interest.
Due Date: 11-08-2018
This FOA will provide support for the center that will supply the infrastructure needed to support research coordination, collaboration, and dissemination of advances made by the NIDDK funded Human Islet Research Network (HIRN).
Due Date: 11-11-2018
An integrated approach to test interventions for opioid misuse and addiction in communities hit hard by the opioid crisis. This study is a part of the NIH initiative, Helping to End Addiction Long-term (HEAL).
Due Date: 11-13-2018
Applicants may request $250,000-$1,000,000 annually for up to three years. The Leona M. and Harry B. Helmsley Charitable Trust, in partnership with the Chan Zuckerberg Initiative, has issued a request for applications to support the continued development of the Human Cell Atlas, an international effort to map all cells in the human body.
Due Date: 11-17-2018
This FOA is associated with the Beau Biden Cancer MoonshotSM Initiative that is intended to accelerate cancer research. The purpose of this FOA is to establish centers of collaborating investigators with the goal of identifying and advancing research opportunities for translating immunotherapy concepts for children and adolescents with cancer toward clinical applications.
Due Date: 08-25-2018
This FOA encourages Small Research Grant (R03) applications, and expresses AHRQ priority areas of interest for ongoing small research projects.
Due Date: 11-23-2018
This FOA is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or two investigators.
Due Date: 11-27-2018
The overarching purpose of this FOA is to promote the validation of strong candidate biomarkers and endpoints for pain that can be used to facilitate the development of non-opioid pain therapeutics from discovery through Phase II clinical trials.
Due Date: 11-22-2018
This grants support exploratory and developmental research projects by providing support for the early and conceptual stages of pain target discovery and validation projects.
Due Date: 11-28-2018
The award provides grants to early-career physician scientists to facilitate their transition to independent clinical research careers.
Due Date: 11-28-2018
This FOA will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical validation due to preanalytical variability in tumor tissue biopsies and blood biospecimens utilized as "liquid biopsies."
Due Date: 11-30-2018
The National Blood Foundation awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.
Due Date: 12-03-2018
The purpose of the updated ViCTER program is to use the R01 mechanism to foster and promote early-stage transdisciplinary collaborations and/or translational research efforts among fundamental (technology and mechanism oriented), clinical (patient-oriented) and population-based researchers in the environmental health field. The newly established collaborative teams will come together in common interest to investigate potential linkages between human health and one or more environmental stressor(s).
Due Date: 12-04-2018
The purpose of this one year, $20,000 award is to provide supplementary funding during the pilot phase of basic, translational, or clinical research projects in autoimmune liver disease (e.g. autoimmune hepatitis, primary sclerosing cholangitis, primary biliary cholangitis) in preparation for future grant applications by the recipient.
Due Date: 12-05-2018
The objective of the award is to provide longer-term support to NIDCR-funded investigators, who are in their mid-career stage, and have outstanding records of research productivity, mentorship, and professional service to the research community.
Due Date: 12-31-2018
In Alzheimer¿s disease, Muscular Dystrophy, Epilepsy, Gulf War Syndrome, Kidney Cancer, Lupus, Parkinson¿s disease, Prostate Cancer, Reconstructive Transplant, and Defense Medical Research.
Due Date: 12-06-2018
This FOA encourages applications from integrative teams and individual investigators for projects to determine the mechanisms underlying the contribution of these risk-associated genes and their variants for Type 1 Diabetes (T1D). The purpose is to accelerate the discovery of function of the causal genes and variants that influence the risk for disease.
Due Date: 12-06-2018
Understanding Skeletal Effects of Type 1 Diabetes (R01 Clinical Trial Optional)
Due Date: 12-11-2018
This FOA invites new applications to participate in the HIRN-CHIB. NIDDK will support the development of a microphysiological system (MPS) that allows the study of interactions between primary human islets or assembled islet spheroids (organoids made up of human beta/alpha/delta/other cells) and immune cells within a 3D microenvironment to mimic aspects of the autoimmune process and its regulation.
Due Date: 12-13-2018
The purpose of this FOA is to support the development and validation of modeling and simulation methods and related tools to examine HIV transmission dynamics, make epidemic projections, and estimate the impact of HIV treatment and prevention. Investigators are expected to share these resources with other researchers.
Due Date: 12-13-2018
SPAN will facilitate testing of up to 6 promising neuroprotective drugs or interventions to be given prior to or at the time of reperfusion in experimental models of ischemic stroke (e.g., transient middle cerebral artery occlusion). If successful, this network will accelerate the identification of the most promising neuroprotective therapies for future pivotal clinical trials and span the gap between preclinical and clinical testing, in a cost-and time-effective fashion.
Due Date: 12-14-2018
The ongoing opioid epidemic and overdose death crisis present an urgent public health need to quickly expand the network to 1) increase the network¿s scientific and clinical research capabilities, and 2) to better cover geographic regions across the U.S. and regions most impacted by the opioid overdose epidemic.
Due Date: 07-23-2018
To give research teams extra time to consider their applications, PCORI posted five research funding preannouncements. Two preannouncements describe soon-to-be-reopened funding opportunities; one focuses on medication-assisted treatment delivery for pregnant women with substance use disorders and the other focuses on symptom management for advanced illnesses. A third preannouncement focuses on addressing health disparities and a fourth on improving methods for conducting patient-centered outcomes research. The fifth preannouncement will focus on the implementation of effective shared decision making approaches in healthcare settings.
Due Date: 06-15-2018
The NIH Common Fund has established the Gabriella Miller Kids First Pediatric Research Program (Kids First) to develop a pediatric research data resource populated by genome sequence and phenotype data that will be of high value for the communities of investigators who study the genetics of childhood cancers and/or structural birth defects.
Due Date: 04-09-2018
The CDMRP is providing information to allow investigators time to plan and develop ideas for submission to anticipated FY18 funding opportunities for ALS, MS, breast and ovarian cancers, and bone marrow failure research.
This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.
Due Date: 12-31-2017
NIH is offering funding for administrative supplements to encourage and improve the diversity of the research workforce. This funding can help recruitment efforts and support for students, postdoctorates and eligible investigators from groups that have been underrepresented in health-related research.
Due Date: 12-29-2017
This FOA calls for research on the health of transgender and gender nonconforming people of all ages, who are questioning their gender identity and those individuals who are making or who have made a transition from being identified as one gender to the other. This group encompasses individuals whose gender identity differs from the sex on their original birth certificate or whose gender expression varies significantly from what is traditionally associated with or typical for that sex.
The objective of the award is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.
This FOA will support small grants on primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for primary immunodeficiency diseases.
The NIH Commons Credits Model is a time- and cost-efficient way for NIH-funded biomedical investigators to gain cloud computing support for their current research as well as pave the way toward better accessibility, interoperability, and reuse of digital objects for future research. This is not a grant; this funding is recommended to supplement current NIH grants or to jump start a related grant in the biomedical space.
This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available
Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.
This FOA invites R01 applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders.
This FOA encourages applications that propose to conduct secondary analyses of publicly available NICHD-funded data sets or stored biospecimens. The goal of this program is to facilitate innovative yet cost-effective research utilizing data and biospecimens collected with NICHD resources.
The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.
Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.
Due Date: 12-17-2018
The applications for a seven-year pragmatic trial from a network or consortium of health care delivery systems are requested, which together cover most of the geographic regions of the U.S., and a data coordinating center to assess the overall risks and benefits of statins in adults 75 years of age and older without clinical cardiovascular disease.
Due Date: 12-24-2018
This FOA is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of NIGMS and are beyond the scope of one or two investigators
Due Date: 01-02-2019
Seeks highly creative and conceptually innovative high-risk research with the potential to accelerate critical discoveries or major advancements that will significantly impact military health and medicine.
Due Date: 01-03-2019
The purpose of this FOA is to solicit applications to support a Leadership Group for a Clinical Research Network on Antibacterial Resistance (AR), which was initiated to develop, implement, and manage a clinical research program to address key clinical research questions in AR.
Due Date: 01-04-2019
The Agency for Healthcare Research and Quality (AHRQ) seeks applications to disseminate patient-centered outcomes research (PCOR) findings directly to primary care practices and support practices in implementing PCOR clinical and organizational findings. Applicants must propose a comprehensive plan that uses evidence-based strategies designed to improve the delivery of patient-centered approaches to identifying and managing unhealthy alcohol use among adults, including screening and brief intervention and medication assisted therapy.
Due Date: 01-14-2019
The purpose of this FOA is to support research utilizing MCS that would result in an increased understanding of the biologic effects, use as sole or combined therapy, insights into patient/MCS management, innovative use/application or improved outcomes for the treatment of heart failure.
Due Date: 01-22-2019
The MRI Program serves to increase access to multi-user scientific and engineering instrumentation for research and research training in our Nation's institutions of higher education and not-for-profit scientific/engineering research organizations. An MRI award supports the acquisition or development of a multi-user research instruments.
Due Date: 02-01-2019
This FOA invites applications to provide infrastructure support for advancing development of specific high-priority areas of behavioral and social research of relevance to aging. The infrastructure support will facilitate research networks through meetings, conferences, small-scale pilots, short-term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and build resources for advancing aging-relevant research in the field at large. Network applications are limited to the following areas: (1) Midlife Reversibility of Biobehavioral Risk Associated with Early Life Adversity, (2) Stress Measurement, (3) Reproducibility in the Social and Behavioral Sciences, (4) Life Course Health Disparities at Older Ages, (5) Genomics of Behavioral and Social Science, (6) Integrating Animal Models to Inform Behavioral and Social Research on Aging, and (7) Rural Aging.
Due Date: 02-01-2019
This FOA invites applications to provide infrastructure support for advancing development of specific high-priority areas of behavioral and social research of relevance to Alzheimer's disease and Alzheimer's disease related dementias. The infrastructure support will facilitate research networks through meetings, conferences, small-scale pilots, short-term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and build resources for advancing aging-relevant research in the field at large.
Due Date: 02-04-2019
The purpose of this FOA is to support the development of a Clin-STAR Coordinating Center that will organize activities and provide research resources for clinician-investigators across the U.S. who are focusing their careers on aging research.
Due Date: 02-15-2019
The purpose of this FOA is to solicit applications for the VTEUs to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC).
Due Date: 02-28-2019
An opportunity for junior faculty and postdocs in diabetes translation research to submit pilot applications for funding. The Pilot and Feasibility Program of the Georgia Center for Diabetes Translation Research is a center-wide activity designed to support investigators in conducting studies that address the priority focal areas of GDTRC¿s Cores: Design and Evaluation, Engagement and Behavior Change, and Disparities.
Due Date: 12-14-2018
The initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This FOA is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This FOA intends to support disease-focused translational studies.
Due Date: 09-27-2018
The NIH Common Fund announces FY 2019 funding opportunity for the NIH Director's Early Independence Awards in the High-Risk, High-Reward Research program. The program provides unique opportunities for exceptionally creative scientists to pursue highly innovative approaches to address major challenges in biomedical or behavioral research.